Genelux Corp. (GNLX)
2.24
+0.24
(+12.00%)
USD |
NASDAQ |
Nov 18, 16:00
2.24
0.00 (0.00%)
After-Hours: 19:20
Genelux Price : 2.24 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 1.84 | 2.05 | 1.82 | 2.00 | 251779.0 |
| Nov 16, 2026 | 1.94 | 2.02 | 1.855 | 1.92 | 278109.0 |
| Nov 13, 2026 | 1.92 | 1.960 | 1.83 | 1.865 | 179403.0 |
| Nov 12, 2026 | 1.88 | 1.95 | 1.81 | 1.90 | 137321.0 |
| Nov 11, 2026 | 1.97 | 2.00 | 1.86 | 1.88 | 292955.0 |
| Nov 10, 2026 | 2.01 | 2.100 | 1.92 | 1.95 | 93184.00 |
| Nov 09, 2026 | 2.03 | 2.09 | 1.935 | 2.07 | 234718.0 |
| Nov 06, 2026 | 1.83 | 2.02 | 1.81 | 1.96 | 323774.0 |
| Nov 05, 2026 | 1.94 | 1.94 | 1.77 | 1.82 | 228582.0 |
| Nov 04, 2026 | 1.95 | 2.01 | 1.862 | 1.96 | 310605.0 |
| Nov 03, 2026 | 2.01 | 2.065 | 1.91 | 1.92 | 287998.0 |
| Nov 02, 2026 | 2.11 | 2.18 | 1.952 | 2.00 | 526296.0 |
| Oct 30, 2026 | 2.07 | 2.11 | 2.00 | 2.08 | 209676.0 |
| Oct 29, 2026 | 2.27 | 2.27 | 2.085 | 2.10 | 120302.0 |
| Oct 28, 2026 | 2.06 | 2.24 | 1.98 | 2.21 | 523910.0 |
| Oct 27, 2026 | 1.92 | 2.07 | 1.86 | 2.05 | 1.452M |
| Oct 26, 2026 | 2.00 | 2.12 | 1.87 | 1.91 | 494702.0 |
| Oct 23, 2026 | 2.02 | 2.07 | 1.90 | 2.00 | 648745.0 |
| Oct 22, 2026 | 2.04 | 2.35 | 1.96 | 1.98 | 947444.0 |
| Oct 21, 2026 | 2.53 | 2.57 | 2.018 | 2.07 | 850725.0 |
| Oct 20, 2026 | 2.43 | 2.612 | 2.43 | 2.50 | 331726.0 |
| Oct 19, 2026 | 2.42 | 2.470 | 2.40 | 2.45 | 161491.0 |
| Oct 16, 2026 | 2.48 | 2.520 | 2.355 | 2.42 | 277873.0 |
| Oct 15, 2026 | 2.40 | 2.51 | 2.33 | 2.48 | 796527.0 |
| Oct 14, 2026 | 2.48 | 2.52 | 2.32 | 2.32 | 410559.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.84 |
| Alnylam Pharmaceuticals, Inc. | 149.48 |
| Anika Therapeutics, Inc. | 13.62 |
| Savara, Inc. | 4.735 |
| Arrowhead Pharmaceuticals, Inc. | 43.12 |
Price Related Metrics
| PS Ratio | 12048.72 |
| PEG Ratio | -3.837 |
| Price to Book Value | 11.10 |
| Earnings Yield | -39.51% |
| Market Cap | 101.03M |
| PEGY Ratio | -3.837 |